AVP and autosomal dominant polycystic kidney disease: Risk prediction is likely to be enhanced by biomarkers, some of which have demonstrated predictive value in adult ADPKD (plasma copeptin, urinary monocyte chemoattractant protein-1), and which require research in children [19, 20, 36, 38].